Supplemental Materials and Methods
Step Study and the intestinal biopsies taken from the 29 subjects in this study was 866 days (mean 918, σ 168). The 29 study subjects were healthy US men who have sex with men aged 25 to 53 years (median and mean 38). At the time of entry into the original Step Study the subjects were at high risk of HIV-1 acquisition on the basis of reported unprotected anal intercourse with a male partner or anal intercourse with two or more male partners in the 6 months before enrollment. 1 Risk was not an eligibility criteria for enrollment into the HVTN 905 protocol and thus was not assessed again before 905 study entry. Subjects who tested positive for HIV infection, rectal gonorrhea or chlamydia infection; SUPPLEMENTAL DIGITAL CONTENT 2 who had clinical suspicion of inflammatory bowel disease; who were diagnosed with a bleeding or other hematological disorder at the screening visit; who had inserted a foreign object into the anus within three days prior to the scheduled procedure; or who were not willing to abstain from receptive anal intercourse from 3 days prior to 7 days after the biopsy were excluded from the study. 
Acquisition and Analysis of Stained Tissue Sections
A sequence of slightly overlapping 20x images covering each stained tissue section in its entirety was acquired on a Zeiss Imager Z2 microscope using TissueFAXS Image Acquisition and Management Software (TissueGnostics, Vienna, Austria). Each stained marker was acquired separately as a monochrome image. Overlapping images were stitched together using the TissueStitching function of TissueFAXS ( Figure 1A ). All acquired images were exported to the TissueQuest Cell Analysis Software (TissueGnostics). Monochrome images were superimposed and rendered in pseudo-colors as depicted in Figure 1B Isotype control slides were used to determine the overall background in our data set. Double isotype controls were negative (Figure 2A ), and single isotype controls for the phenotypic markers also showed only negligible background (not shown). Single isotype controls for CCR5, a representative set of which is shown in Figure 2A, 
CCR5 Genotyping
We genotyped all participants for hetero-or homozygosity of the CCR5∆32 mutation by PCR and DNA restriction fragment length analysis. 10 Among the 29 subjects, we identified one CCR5∆32 homozygote and one CCR5∆32 heterozygote. The CCR5∆32 homozygote individual tested completely negative for CCR5 expression in his colon and rectum biopsies, which provided an additional specificity control for the anti-CCR5 antibody. This individual was excluded from statistical analysis. The CCR5∆32 heterozygote individual did not exhibit unusually low CCR5 expression levels and was not excluded from analysis.
Data Analysis
The numbers of total nucleated, single marker positive and double marker positive cells, as well as the acquired area in mm 2 , were exported to the Statistical Center for HIV/AIDS Research and Prevention (SCHARP), which independently from the laboratory operator calculated cell percentages and densities/mm 2 and conducted the statistical analysis. Data sets were statistically compared between rectum and colon by Mann-Whitney U test when using all data in each comparison group, and by Wilcoxon signed-rank test when using only paired data where each data pair was derived from a colon and a rectum biopsy obtained from the same individual at the same time point.
